Homodimerization of the p51 subunit of HIV-1 reverse transcriptase

Biochemistry

Volumn 49, Issue 13, 2010, Pages 2821-2833

  Zheng, Xunhai ^a   Mueller, Geoffrey A ^a   Cuneo, Matthew J ^a   Derose, Eugene F ^a   London, Robert E ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFORMATIONAL SELECTION; DIMER CONCENTRATIONS; DIMER FORMATION; DIMER INTERFACE; EXPERIMENTAL CONDITIONS; HETERODIMERS; HIV REVERSE TRANSCRIPTASE; HIV-1 REVERSE TRANSCRIPTASE; HOMODIMERIZATION; HOMODIMERS; MICROMOLAR CONCENTRATION; NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS; SMALL ANGLE X-RAY SCATTERING; SUBDOMAIN;

DIMERIZATION; ENZYME INHIBITION; ENZYMES; IONIC STRENGTH; MONOMERS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE; VIRUSES; X RAY SCATTERING;

CONFORMATIONS;

ACETONITRILE; DIMER; HOMODIMER; MONOMER; NEVIRAPINE; POTASSIUM CHLORIDE; PROTEIN P51; PROTEIN P66; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIMERIZATION; GEL PERMEATION CHROMATOGRAPHY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

HIV REVERSE TRANSCRIPTASE; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION, MISSENSE; NEVIRAPINE; OSMOLAR CONCENTRATION; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN SUBUNITS; SCATTERING, SMALL ANGLE; X-RAYS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77950431002     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi902116z     Document Type: Article

References (56)

1. Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debre, P., and Leibowitch, J. (1997) Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease. Science 277, 112-116. (Pubitemid 27450659)
2. Staszewski, S., Morales-Ramirez, J., Tashima, K. T., Rachlis, A., Skiest, D., Stanford, J., Stryker, R., Johnson, P., Labriola, D. F., Farina, D., Manion, D. J., and Ruiz, N. M. (1999) Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N, Engel. J. Med. 341, 1865-1873.
3. Sluis-Cremer, N., Arion, D., Abram, M. E., and. Parniak, M. A. (2004) Proteolytic processing of an HIV-1 pol polyprotein precursor: Insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation. Int. J. Biochem. Cell Biol. 36, 1836-1847.
4. Tachedjian, G., Orlova, M., Sarafianos, S. G., Arnold, E., and Goff, S. P. (2001) Nonnucleoside reverse transcriptase inhibitors are chemical enhancers of dimerization of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A. 98, 7188-7193. (Pubitemid 32567924)
5. Venezia, C. F., Howard, K. J., Ignatov, M. E., Holladay, L. A., and Barkley, M. D. (2006) Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase. Biochemistry 45, 2779-2789. (Pubitemid 43334527)
6. Srivastava, S., Sluis-Cremer, N., and Tachedjian, G. (2006) Dimerization of human immunodeficiency virus type 1 reverse transcriptase as an antiviral target. Curr. Pharm, Des. 12, 1879-1894.
7. Morris,M.C.,Robert-Hebmann,V.,Chaloin,L.,Mery,J.,Heitz,F.,Devaux,C., Goody,R.S.,andDivita,G.(1999)AnewpotentHIV-1reversetranscriptaseinhibitor. Asyntheticpeptidederivedfromtheinterfacesubunitdomains.J.Biol.Chem.274, 24941-24946.(Pubitemid129529385)
8. Divita, G., Restle, T., and. Goody, R. S. (1993) Characterization of the dimerization process of HIV-1 reverse transcriptase heterodimer using intrinsic protein fluorescence. FEBS Lett. 324, 153-158.
9. Divita, G., Restle, T., Goody, R. S., Chermann, J. C., and. Baillon, J. G. (1994) Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain. J. Biol. Chem. 269, 13080-13083.
10. Camarasa, M. J., Velazquez, S., San-Felix, A., Perez-Perez, M. J., Bonache, M. C., and De Castro, S. (2006) TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: Recent progress. Curr. Pharm. Des. 12, 1895-1907.
11. Sluis-Cremer, N., Hamamouch, N., San Felix, A., Velazquez, S., Balzarini, J., and Camarasa, M. J. (2006) Structure-activity relationships of [2' ,5'-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-3'spiro-5"- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine derivatives as inhibitors of HIV-1 reverse transcriptase dimerization. J. Med. Chem. 49, 4834-4841.
12. Depollier, J., Hourdou, M. L., Aldrian-Herrada, G., Rothwell, P., Restle, T., and Divita, G. (2005) Insight into the mechanism of a peptide inhibitor of HIV reverse transcriptase dimerization. Biochemistry. 44, 1909-1918. (Pubitemid 40223620)
13. Grohmann, D., Corradi, V., Elbasyouny, M., Baude, A., Horenkamp, F., Laufer, S. D., Manetti, F., Botta, M., and Restle, T. (2008) Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization. ChemBioChem 9, 916-922.
14. Agopian, A., Gros, E., Aldrian-Herrada, G., Bosquet, N., Clayette, P., and. Divita, G. (2009) A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility. J. Biol. Chem. 284, 254-264.
15. Goel, R., Beard, W. A., Kumar, A., Casas-Finet, J. R., Strub, M. P., Stahl, S. J., Lewis, M. S., Bebenek, K., Becerra, S. P., and Kunkel, T. A.; et al. (1993) Structure/function studies of HIV-1(1) reverse transcriptase: Dimerization-defective mutant L289K. Biochemistry 32, 13012-13018. (Pubitemid 24005906)
16. Ghosh, M., Jacques, P. S., Rodgers, D. W., Ottman, M., Darlix, J. L., and Le Grice, S. F. (1996) Alterations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization. Biochemistry 35, 8553-8562. (Pubitemid 26240189)
17. Wohrl, B. M., Krebs, R., Thrall, S. H., Le Grice, S. F., Scheidig, A. J., and Goody, R. S. (1997) Kinetic analysis of four HIV-1 reverse transcriptase enzymes mutated in the primer grip region of p66. Implications for DNA synthesis and dimerization. J. Biol. Chem. 272, 17581-17587. (Pubitemid 27311192)
18. Tachedjian, G., Aronson, H. E., and Goff, S. P. (2000) Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase. Proc. Natl. Acad. Sci. U.S.A 97, 6334-6339. (Pubitemid 30412714)
19. Sluis-Cremer, N., and Tachedjian, G. (2002) Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules. Eur. J. Biochem, 269, 5103-5111. (Pubitemid 35340819)
20. Auwerx, J., Van Nieuwenhove, J., Rodriguez-Barrios, F., de Castro, S., Velazquez, S., Ceccherini-Silberstein, F., De Clercq, E., Camarasa, M. J., Perno, C. F., Gago, F., and. Baizarini, J. (2005) The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs. FERS Lett. 579, 2294-2300.
21. Balzarini, J., Auwerx, J., Rodriguez-Barrios, F., Chedad, A., Farkas, V., Ceccherini-Silberstein, F., Garcia-Aparicio, C., Velazquez, S., De Clercq, E., Perno, C. F., Camarasa, M. J., and Gago, F. (2005) The amino acid Asn 136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors. Mol. Pharmacol. 68, 49-60. (Pubitemid 41007052)
22. Mulky, A., Sarafianos, S. G., Jia, Y., Arnold, E., and Kappes, J. C. (2005) Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions. J. Mol. Biol. 349, 673-684. (Pubitemid 40725947)
23. Mulky, A., Vu, B. C., Conway, J. A., Hughes, S. H., and Kappes, J. C. (2007) Analysis of amino acids in the β7-β8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication. J. Mol. Biol. 365, 1368-1378. (Pubitemid 46061425)
24. Wapling, J., Moore, K. L., Sonza, S., Mak, J., and Tachedjian, G. (2005) Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer. J. Virol. 79, 10247-10257. (Pubitemid 41098566)
25. Figueiredo, A., Zelina, S., Sluis-Cremer, N., and Tachedjian, G. (2008) Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stability. Curr. HIV Res. 130-137.
26. Cabodevilla, J. F., Odriozola, L., Santiago, E., and. Martinez-Irujo, J. J. (2001) Factors affecting the dimerization of the p66 form of HIV-1 reverse transcriptase. Eur. J. Biochem. 268, 1163-1172.
27. Restle, T., Muller, B., and. Goody, R. S. (1990) Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J. Biol. Chem. 265, 8986-8988.
28. Divita, G., Rittinger, K., Geourjon, C., Deleage, G., and Goody, R. S. (1995) Dimerization kinetics of HIV-1 and HIV-2 reverse transcriptase: A two step process. J. Mol. Biol. 245, 508-521.
29. Divita, G., Rittinger, K., Restle, T., Immendorfer, U., and Goody, R. S. (1995) Conformational stability of dimeric HIV-1 and HIV-2 reverse transcriptases. Biochemistry 34, 16337-16346. (Pubitemid 26006477)
30. Sluis-Cremer, N., Dmitrienko, G. I., Balzarini, J., Camarasa, M. J., and Parniak, M. A. (2000) Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[spiro[4″-amino2″,2″-dioxo- 1″,2″-oxathiole-5″,3′-[2″,5″'-bis-O-(tert- butyldimethylsilyl)β-D-ribofuranosyl]]]-3-ethvlthvmine. Biochemistrey 39, 1427-1433. (Pubitemid 30090712)
31. Tachedjian, G., Moore, K. L., Goff, S. P., and Sluis-Cremer, N. (2005) Efavirenz enhances the proteolytic processing of an HIV-1 pol polyprotein precursor and reverse transcriptase homodimer formation. FEBS Lett. 579, 379-384. (Pubitemid 40092415)
32. Bavand, M. R., Wagner, R., and Richmond, T. J. (1993) HIV-1 reverse transcriptase: Polymerization properties of the p51 homodimer compared to the p66/p51 heterodimer. Biochemistry 32, 10543-10552.
33. Sluis-Cremer, N., Kempner, E., and Parniak, M. A. (2003) Structureactivity relationships in HIV-1 reverse transcriptase revealed by radiation target analysis. Protein Sci., 12, 2081-2086. (Pubitemid 37022829)
34. Kensch, O., Restle, T., Wohrl, B. M., Goody, R. S., and Steinhoff, H. J. (2000) Temperature-dependent equilibrium between the open and closed conformation of the p66 subunit of HIV-1 reverse transcriptase revealed by site-directed spin labelling. J. Mol. Biol. 301, 1029-1039.
35. Studier, F. W. (2005) Protein production by auto-induction in high density shaking cultures. Protein Expression Purif. 41, 207-234.
36. Muchmore, D. C., Mcintosh, L. P., Russell, C. B., Anderson, D. E., and Dahlquist, F. W. (1989) Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol. 177, 44-73.
37. Hou, E. W., Prasad, R., Beard, W. A., and Wilson, S. H. (2004) High-level expression and purification of untagged and histidinetagged HIV-1 reverse transcriptase. Protein Expression Purif. 34, 75-86. (Pubitemid 38272315)
38. 13C]methionine HIV-1 reverse transcriptase by NMR spectroscopy. Antiviral Res. 84, 205-214.
39. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
40. Johnson, B. A., and. Blevins, R. A. (1994) Nmr View: A Computer Program for the Visualization and Analysis of Nmr Data. J. Biomol. NMR 4, 603-614.
41. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J., and Svergun, D. I. (2003) PRIMUS: A Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36, 1277-1282.
42. Svergun, D., Barberato, C., and Koch, M. H. J. (1995) CRYSOL: A program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28, 768-773. (Pubitemid 3014671)
43. Spallarossa, A., Cesarini, S., Ranise, A., Ponassi, M., Unge, T., and Bolognesi, M. (2008) Crystal structures of HIV-1 reverse transcriptase complexes with thiocarbamate non-nucleoside inhibitors. Biochem. Biophys. Res. Commun. 365, 764-770. (Pubitemid 350234856)
44. Bauman, J. D., Das, K., Ho, W. C., Baweja, M., Himmel, D. M., Clark, A. D., Oren, D. A., Boyer, P. L., Hughes, S. H., Shatkin, A. J., and Arnold, E. (2008) Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res. 36, 5083-5092.
45. Wang, J., Smerdon, S. J., Jager, J., Kohlstaedt, L. A., Rice, P. A., Friedman, J. M., and Steitz, T. A. (1994) Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. U.S.A. 91, 7242-7246. (Pubitemid 24226839)
46. Smerdon,S.J.,Jager,J.,Wang,J.,Kohlstaedt,L.A.,Chirino,A.J.,Friedman,J.M., Rice,P.A.,andSteitz,T.A.(1994) Structureofthebindingsitefornonnucleosideinhibitorsofthereversetranscriptaseofh umanimmunodeficiencyvirustype1.Proc.Natl.Acad.Sci.U.S.A.91,3911-3915. (Pubitemid24139542)
47. Ren, J., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., and Stuart, D.; et al. (1995) High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat. Struct. Biol. 2, 293-302.
48. Rowley, G. L., Ma, Q. F., Bathurst, I. C., Barr, P. J., and Kenyon, G. L. (1990) Stabilization and activation of recombinant human immunodeficiency virus-1 reverse transcriptase-P66. Biochem, Bio- phys. Res. Commun. 167, 673-679.
49. Andreola, M. L. (2009) Therapeutic potential of peptide motifs against HIV-1 reverse transcriptase and integrase. Curr. Pharm, Des. 15, 2508-2519.
50. Dufour, E., El Dirani-Diab, R., Boulme, F., Fournier, M., Nevinsky, G., Tarrago-Litvak, L., Litvak, S., and Andreola, M. L. (1998) p66/ p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1: Interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors. Eur. J. Biochem, 251, 487-495. (Pubitemid 28080951)
51. Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., and Steitz, T. A. (1992) Crystal-Structure at 3.5 Angstrom Resolution of HIV-1 Reverse-Transcriptase Complexed with an Inhibitor. Science 256, 1783-1790.
52. Ren, J., Nichols, C., Bird, L., Chamberlain, P., Weaver, K., Short, S., Stuart, D. I., and Stammers, D. K. (2001) Structural mechanisms of drug resistance for mutations at codons 181 and. 188 in HIV-1 reverse transcriptase and the improved resilience of second generation nonnucleoside inhibitors. J. Mol. Biol. 312, 795-805. (Pubitemid 33116741)
53. Chamberlain, P. P., Ren, J., Nichols, C. E., Douglas, L., Lennerstrand, J., Larder, B. A., Stuart, D. I., and. Stammers, D. K. (2002) Crystal structures of zidovudine- or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215. J. Virol. 76, 10015-10019.
54. Veneria, C. F., Meany, B. J., Braz, V. A., and Barkley, M. D. (2009) Kinetics of association and dissociation of HIV-1 reverse transcriptase subunits. Biochemistry. 48, 9084-9093.
55. Pari, K., Mueller, G. A., DeRose, E. F., Kirby, T. W., and London, R. E. (2003) Solution structure of the RN'ase H domain of the HIV-1 reverse transcriptase in the presence of magnesium. Biochemistry. 42, 639-650. (Pubitemid 36133288)
56. Lowe, D. M., Aitken, A., Bradley, C., Darby, G. K., Larder, B. A., Powell, K. L., Purifoy, D. J., Tisdale, M., and Stammers, D. K. (1988) HIV-1 reverse transcriptase: Crystallization and analysis of domain structure by limited proteolysis. Biochemistry 27, 8884-8889.